Enliven Therapeutics GAAP EPS of -$0.36 Source link Like this:Like Loading… Related Post navigation Arhaus forecasts FY2026 net revenue of $1.465B-$1.485B while targeting 25% e-commerce penetration over 5 years (NASDAQ:ARHS) Tesla to end cybertruck production at Texas factory by mid-2027 to ramp up Cybercab output, Musk says
